{
    "clinical_study": {
        "@rank": "46885", 
        "arm_group": [
            {
                "arm_group_label": "Neurofeedback and Physical Exercise", 
                "arm_group_type": "Experimental", 
                "description": "This group will undergo neurofeedback intervention in the fMRI scanner in weeks 1,5 and 12. They will also undergo physical exercise training on WiiFit device once a week after the first month till the end of the study at 12 weeks."
            }, 
            {
                "arm_group_label": "Physical Exercise", 
                "arm_group_type": "Active Comparator", 
                "description": "This group will undergo Physical Exercise intervention on the WiiFit device 3 times a week in the first month and once a week after the first month till the end of the study at 12 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to train patients with Parkinson's Disease to increase activity in a\n      brain area that is involved in the control of motor functions with the use of a technique\n      called real-time fMRI neurofeedback (NF) along with regular physical exercise. This will be\n      a randomised and controlled clinical trial to evaluate the benefits of a novel treatment.\n      The investigators expect NF training along with physical exercise practise to better improve\n      motor functions compared to physical exercise alone."
        }, 
        "brief_title": "Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  People with Parkinson's Disease\n\n          -  Hoehn and Yahr stages 1-3 of the disease\n\n        Exclusion Criteria:\n\n          -  Patients with dementia or significant comorbidity\n\n          -  those who fail the safety screening to go into an MRI scanner\n\n          -  those who cannot travel to the University"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867827", 
            "org_study_id": "SPON997-11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Neurofeedback and Physical Exercise", 
                "intervention_name": "Neurofeedback and Physical Exercise", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Physical Exercise", 
                "intervention_name": "Physical Exercise", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 3, 2013", 
        "location": {
            "contact": {
                "email": "LindenD@cardiff.ac.uk", 
                "last_name": "Linden, MD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Cardiff", 
                    "country": "United Kingdom", 
                    "state": "Wales", 
                    "zip": "CF14 4XN"
                }, 
                "name": "School of Medicine, Cardiff University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease", 
        "overall_contact": {
            "email": "LindenD@cardiff.ac.uk", 
            "last_name": "David Linden, MD, PhD", 
            "phone": "02920 687064", 
            "phone_ext": "87064"
        }, 
        "overall_official": {
            "affiliation": "Cardiff University", 
            "last_name": "David Linden, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS)", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS) in 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867827"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Cardiff University", 
            "investigator_full_name": "David Linden", 
            "investigator_title": "Professor of Translational Neuroscience", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) at 4 weeks"
            }, 
            {
                "measure": "Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) in 12 weeks"
            }, 
            {
                "measure": "Change from baseline in the 'Actigraph'", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline in the 'Actigraph' at 12 weeks"
            }, 
            {
                "measure": "Change from baseline in the 'GaitRite'", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline in the 'GaitRite' at 12 weeks"
            }
        ], 
        "source": "Cardiff University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cardiff University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}